Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice
Clinical trial NCT07615166 · COMPLETED
Trial details
- NCT number
- NCT07615166
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-22
- Primary completion
- 2026-06-30
- Enrollment
- 996
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.